{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:19:35Z","timestamp":1790720375704,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.lungcan.2016.04.014","type":"journal-article","created":{"date-parts":[[2016,6,24]],"date-time":"2016-06-24T07:45:55Z","timestamp":1466754355000},"page":"23-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"special_numbering":"C","title":["A phase I trial of the Hedgehog inhibitor, sonidegib (LDE225), in combination with etoposide and cisplatin for the initial treatment of extensive stage small cell lung cancer"],"prefix":"10.1016","volume":"99","clinical-trial-number":[{"clinical-trial-number":"nct01579929","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"M. Catherine","family":"Pietanza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anya M.","family":"Litvak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna M.","family":"Varghese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee M.","family":"Krug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Fleisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerrold B.","family":"Teitcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei I.","family":"Holodny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cami S.","family":"Sima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlin M.","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth K.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen H.","family":"Won","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark G.","family":"Kris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles M.","family":"Rudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2016.04.014_bib0005","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0960-9822(98)70446-4","article-title":"Sonic hedgehog regulates branching morphogenesis in the mammalian lung","volume":"8","author":"Pepicelli","year":"1998","journal-title":"Curr. Biol."},{"key":"10.1016\/j.lungcan.2016.04.014_bib0010","doi-asserted-by":"crossref","first-page":"e232","DOI":"10.1371\/journal.pmed.0030232","article-title":"Predicting survival within the lung cancer histopathological hierarchy using a multi-scale genomic model of development","volume":"3","author":"Liu","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.lungcan.2016.04.014_bib0015","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nature01493","article-title":"Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer","volume":"422","author":"Watkins","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.lungcan.2016.04.014_bib0020","doi-asserted-by":"crossref","DOI":"10.1038\/nm.2473","article-title":"A crucial requirement for Hedgehog signaling in small cell lung cancer","author":"Park","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.lungcan.2016.04.014_bib0025","series-title":"99th AACR Annual Meeting","first-page":"4611","article-title":"A novel HH pathway inhibitor, IPI-926, delays recurrence post-chemotherapy in a primary human SCLC xenograft model","author":"Travaglione","year":"2008"},{"key":"10.1016\/j.lungcan.2016.04.014_bib0030","doi-asserted-by":"crossref","first-page":"196","DOI":"10.4161\/cc.2.3.378","article-title":"Hedgehog signaling: progenitor phenotype in small-cell lung cancer","volume":"2","author":"Watkins","year":"2003","journal-title":"Cell Cycle"},{"key":"10.1016\/j.lungcan.2016.04.014_bib0035","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1158\/1078-0432.CCR-09-2846","article-title":"Targeting Hedgehog\u2014a cancer stem cell pathway","volume":"16","author":"Merchant","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lungcan.2016.04.014_bib0040","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ccr.2008.08.003","article-title":"Expansion of Bcr-Abl-positive leukemic stem cells is dependent on Hedgehog pathway activation","volume":"14","author":"Dierks","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.lungcan.2016.04.014_bib0045","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nature07737","article-title":"Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia","volume":"458","author":"Zhao","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.lungcan.2016.04.014_bib0050","doi-asserted-by":"crossref","first-page":"6063","DOI":"10.1158\/0008-5472.CAN-06-0054","article-title":"Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells","volume":"66","author":"Liu","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.lungcan.2016.04.014_bib0055","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10238-011-0135-8","article-title":"Effects of the Hedgehog pathway inhibitor GDC-0449 on lung cancer cell lines are mediated by side populations","volume":"12","author":"Tian","year":"2012","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.lungcan.2016.04.014_bib0060","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.lungcan.2016.04.014_bib0065","first-page":"e50710","article-title":"Detecting somatic genetic alterations in tumor specimens by exon capture and massively parallel sequencing","author":"Won","year":"2013","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.lungcan.2016.04.014_bib0070","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jmoldx.2014.12.006","article-title":"Memorial sloan kettering-integrated mutation profiling of actionable cancer targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology","volume":"17","author":"Cheng","year":"2015","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.lungcan.2016.04.014_bib0075","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1158\/1078-0432.CCR-13-1710","article-title":"A phase I, multicenter, open-label, first-in-human, dose-escalation study of the oral smoothened inhibitor Sonidegib (LDE225) in patients with advanced solid tumors","volume":"20","author":"Rodon","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lungcan.2016.04.014_bib0080","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S1470-2045(15)70100-2","article-title":"Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial","volume":"16","author":"Migden","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.lungcan.2016.04.014_bib0085","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1200\/JCO.2005.04.8595","article-title":"Randomized phase III trial comparing irinotecan\/cisplatin with etoposide\/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer","volume":"24","author":"Hanna","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2016.04.014_bib0090","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1200\/JCO.2008.20.1061","article-title":"Phase III trial of irinotecan\/cisplatin compared with etoposide\/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124","volume":"27","author":"Lara","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2016.04.014_bib0095","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1200\/JCO.2010.29.3423","article-title":"Randomized phase II study of bevacizumab in combination with chemotherapy in previously untreated extensive-stage small-cell lung cancer: results from the SALUTE trial","volume":"29","author":"Spigel","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2016.04.014_bib0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJMoa0905360","article-title":"Inhibition of the hedgehog pathway in advanced basal-cell carcinoma","volume":"361","author":"Von Hoff","year":"2009","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.lungcan.2016.04.014_bib0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJMoa0902903","article-title":"Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449","volume":"361","author":"Rudin","year":"2009","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.lungcan.2016.04.014_bib0110","doi-asserted-by":"crossref","first-page":"4616","DOI":"10.1073\/pnas.0732813100","article-title":"Identification of a small molecule inhibitor of the hedgehog signaling pathway: effects on basal cell carcinoma-like lesions","volume":"100","author":"Williams","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lungcan.2016.04.014_bib0115","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1158\/1078-0432.CCR-13-1711","article-title":"A five-gene hedgehog signature developed as a patient preselection tool for hedgehog inhibitor therapy in medulloblastoma","volume":"21","author":"Shou","year":"2015","journal-title":"Clin. Cancer Res."},{"issue":"suppl, abstr 7508","key":"10.1016\/j.lungcan.2016.04.014_bib0120","article-title":"Three arm randomized phase II study of cisplatin and etoposide (CE) versus CE with either vismodegib or cixutumumab for patients with extensive stage small cell lung cancer (ECOG1508)","volume":"31","author":"Belani","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2016.04.014_bib0125","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1158\/1078-0432.CCR-14-0507","article-title":"Molecular pathways: novel approaches for improved therapeutic targeting of Hedgehog signaling in cancer stem cells","volume":"21","author":"Justilien","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lungcan.2016.04.014_bib0130","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ccr.2014.01.008","article-title":"The PRKCI and SOX2 oncogenes are coamplified and cooperate to activate Hedgehog signaling in lung squamous cell carcinoma","volume":"25","author":"Justilien","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.lungcan.2016.04.014_bib0135","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/ng.2405","article-title":"Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer","volume":"44","author":"Rudin","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.lungcan.2016.04.014_bib0140","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/ng.2396","article-title":"Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer","volume":"44","author":"Peifer","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.lungcan.2016.04.014_bib0145","doi-asserted-by":"crossref","first-page":"808","DOI":"10.2353\/ajpath.2009.090078","article-title":"Evaluation of circulating tumor cells and serological cell death biomarkers in small cell lung cancer patients undergoing chemotherapy","volume":"175","author":"Hou","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.lungcan.2016.04.014_bib0150","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/JTO.0b013e31823f125d","article-title":"Prognostic impact of circulating tumor cells in patients with small cell lung cancer","volume":"7","author":"Naito","year":"2012","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2016.04.014_bib0155","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1200\/JCO.2010.33.3716","article-title":"Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer","volume":"30","author":"Hou","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2016.04.014_bib0160","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1093\/annonc\/mds138","article-title":"Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor","volume":"23","author":"Hiltermann","year":"2012","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.lungcan.2016.04.014_bib0165","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/nm.3600","article-title":"Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer","volume":"20","author":"Hodgkinson","year":"2014","journal-title":"Nat. Med."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500216302951?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500216302951?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T16:23:41Z","timestamp":1668615821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500216302951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":33,"alternative-id":["S0169500216302951"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2016.04.014","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A phase I trial of the Hedgehog inhibitor, sonidegib (LDE225), in combination with etoposide and cisplatin for the initial treatment of extensive stage small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2016.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}